Strategy update: IDL Diagnostics

Strategy update: IDL Diagnostics

A strategy update with IDL Diagnostics was held on November 27th at Redeye, where CEO Anders Hultman and the management team presented recent achievements, spotlighted key initiatives, and discussed future opportunities looking toward 2026 and beyond. After their...

Meet us at Medica 17-20 November

IDL Diagnostics will be exhibiting  on of the largest medical trade fairs in the works, Medica Dusseldorf starting  November 17-20. Visit Gustav Sten, Xia Jiang and Anders Hultman at Hall1, Booth H69
IDL Biotech is making progress in Africa

IDL Biotech is making progress in Africa

IDL Biotech has now received its first order from the company’s distributor in Uganda, Medilink Lab & Surgical Ltd. The order refers to TUBEX® TF, IDL Biotech’s rapid test for typhoid fever. Uganda will thus be the third country in Africa to which the...
IDL Biotech signs distributor agreement in Ghana

IDL Biotech signs distributor agreement in Ghana

IDL Biotech continues to expand in Africa. IDL Biotech has signed a distributor agreement with Res Health Consult Ltd covering Ghana. The agreement covers the sale of TUBEX® TF. Since its launch in Africa, the company has focused on finding the right partners for...